TP53 and non-small cell lung carcinoma: In NSCLC specifically, recurrently mutated oncogenes and tumor suppressors (TP53, EGFR, KEAP1, and others) have been implicated as regulators of metabolism and major drivers of metabolic reprogramming (Table 1) (44).